Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis -- Ignore unavailable to you. Want to Upgrade?

To: ken whited who wrote (1529)	10/27/1998 3:09:00 PM
From: Robert Busse	Read Replies (2) \| Respond to of 1693

Altho Yahoo says 6 cents, that seems a bit high to me especially since I suspect there will be a few more charges to be taken re the recent restructuring and the departure of Mr Burke, et al.. I'll say 3 cents!!! Did you see the news today that Glaxo has filed a new drug application w/ the FDA for its influenza drug, Relenza. I hope all is going well with Quidel's flu diagnostic test - as far as I know, all is well and it is in clinical trials right now - I expect to see Quidel file for FDA approval of its test in the Spring of 1999. Keep your fingers crossed re the earnings!!!